Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868630928Aexternal-prioritypatent/GB8630928D0/en
Priority claimed from GB878717924Aexternal-prioritypatent/GB8717924D0/en
Application filed by Beecham Group PlcfiledCriticalBeecham Group Plc
Priority claimed from EP87311321Aexternal-prioritypatent/EP0273689B1/de
Application grantedgrantedCritical
Publication of ATE69810T1publicationCriticalpatent/ATE69810T1/de
AT87311321T1986-12-241987-12-22Derivate von n-(2-alkyl-3-mercaptoglutaryl)-alpha-aminosaeure und deren verwendung als collagenaseinhibitoren.
ATE69810T1
(de)
Anwendung von n-(2-(diaethylamino)aethyl>-2-methoxy-4((1-h-4,5ihydro-2-imidazolyl)amino>-5- chlorobenzamid als anxiolytisches und antipsychotisches mittel.